(NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for Dupixent ® (dupilumab) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback